• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Hero Background
    English
    Chinese
    French
    Japanese
    Korean
    German
    Spanish

    Hydrocephalus Market Share

    ID: MRFR/MED/1187-CR
    139 Pages
    Rahul Gotadki
    August 2019

    Hydrocephalus Market Research Report Information by Type (Congenital Hydrocephalus, Acquired Hydrocephalus, Normal-Pressure Hydrocephalus, Ex-Vacuo Hydrocephalus), Diagnostic (CT scan – head, MRI, Head Ultrasound), Treatment (Surgery – Shunt Insertion, Ventriculostomy, Medication), End User (Hospitals & Clinics, Diagnostic Centres, Academic Institutions and Research Organizations) and Regio...

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Hydrocephalus Market Infographic
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0

    Market Share

    Hydrocephalus Market Share Analysis

     The market share positioning strategies within the Hydrocephalus market play a pivotal role in shaping the landscape of medical treatment and innovation for patients suffering from this condition. Hydrocephalus, characterized by an abnormal accumulation of cerebrospinal fluid within the brain, presents challenges and opportunities for medical companies striving to make a difference in patients' lives. In this competitive landscape, companies often employ various strategies to establish and enhance their market share.

    Firstly, companies focus on product innovation and differentiation to capture a significant portion of the Hydrocephalus market. By developing novel treatment options such as shunts, endoscopic third ventriculostomy (ETV), or minimally invasive surgical techniques, companies can attract healthcare providers and patients seeking advanced solutions. Differentiated products not only address unmet medical needs but also position companies as leaders in Hydrocephalus treatment, thus garnering a larger market share.

    Moreover, strategic partnerships and collaborations enable companies to expand their market reach and penetration. Collaborating with healthcare facilities, research institutions, and advocacy groups allows companies to leverage expertise, resources, and networks to promote their products and services effectively. These partnerships not only facilitate product development and clinical trials but also enhance market visibility and credibility, ultimately leading to increased market share.

    Furthermore, effective marketing and promotional campaigns are essential for positioning within the Hydrocephalus market. Companies employ targeted marketing strategies to raise awareness about their products among healthcare professionals, patients, and caregivers. Educational initiatives, participation in medical conferences, and digital marketing campaigns help companies reach their target audience and convey the value proposition of their offerings. By highlighting the benefits, safety, and efficacy of their products, companies can influence prescribing decisions and gain market share in the competitive Hydrocephalus landscape.

    In addition, pricing strategies play a critical role in market share positioning within the Hydrocephalus market. Companies must strike a balance between pricing their products competitively to attract customers while ensuring profitability and sustainability. Flexible pricing models, reimbursement strategies, and patient assistance programs can make treatments more accessible and affordable, thereby increasing market adoption and share.

    Furthermore, market expansion and globalization are key considerations for companies seeking to strengthen their position in the Hydrocephalus market. Expanding into new geographic regions and emerging markets allows companies to tap into underserved patient populations and capitalize on growing healthcare infrastructure. Tailoring products and services to meet local regulatory requirements and cultural preferences enables companies to gain a foothold in diverse markets and diversify their revenue streams, ultimately enhancing market share and competitiveness.

    Lastly, continuous research and development efforts are imperative for maintaining a competitive edge in the Hydrocephalus market. Companies must invest in innovation, technology, and clinical research to address evolving patient needs, improve treatment outcomes, and differentiate their offerings from competitors. By staying abreast of scientific advancements and market trends, companies can anticipate changes in the Hydrocephalus landscape and position themselves as leaders in the field, thereby securing and expanding their market share over time.

    Market Summary

    The global hydrocephalus market is projected to grow from 0.58 USD billion in 2024 to 1.07 USD billion by 2035, reflecting a robust growth trajectory.

    Key Market Trends & Highlights

    Hydrocephalus Key Trends and Highlights

    • The market is expected to experience a compound annual growth rate (CAGR) of 5.77 percent from 2025 to 2035.
    • By 2035, the hydrocephalus market is anticipated to reach a valuation of 1.07 USD billion, indicating substantial growth potential.
    • In 2024, the market is valued at 0.58 USD billion, laying a solid foundation for future expansion.
    • Growing adoption of advanced treatment options due to increasing awareness of hydrocephalus is a major market driver.

    Market Size & Forecast

    2024 Market Size 0.58 (USD Billion)
    2035 Market Size 1.07 (USD Billion)
    CAGR (2025-2035) 5.77%
    Largest Regional Market Share in 2024 latin_america)

    Major Players

    DePuy Synthes, Boston Neurosciences, Medtronic, Integra Life Sciences Corporation, Spiegelberg GmbH & Co. KG, RAUMEDIC Inc, Sophysa SA, Terumo Corporation, Natus Medical Incorporated, Johnson & Johnson Services Inc

    Market Trends

    The key drivers of the market

    The increased incidence of Hydrocephalus in people and infants is a major driver of the Hydrocephalus Industry. According to an academic study in 2019, the incidence of pediatric Hydrocephalus is 88 out of 100,000 births globally. This is an increased incidence of Hydrocephalus in infants. On the other hand, the increase in life-threatening accidents and brain injuries in adults is also driving the growth of the Hydrocephalus Industry. The increased prevalence of the two indicators is a favorable one for the market of Hydrocephalus.

    Significant opportunities

    Besides the increased prevalence of induced Hydrocephalus, the increase in the incidence of neurological disorders due to lifestyle diseases is also an opportunity for the Hydrocephalus Market Size to increase its product portfolio and application. The incidence of congenital defects in the present generation is also increasing. 

    This produces another window of opportunity for expanding the Hydrocephalus Industry Size. All these factors may seem dreary, but they are instrumental in presenting new opportunities to the Market for Hydrocephalus Industry Growth. Another opportunity for Market Growth is the use of advanced surgical techniques with the help of valves. When people become aware of the possible treatment of Hydrocephalus, it will only drive the growth of the Market further.

    Market Restraints

    There are some restraints that limit the Hydrocephalus Industry Growth in the long run. These restraints are no different from the usual restraints that exist in the healthcare sector. With advanced treatment procedures, there is always a chance that an implant or treatment approach will lead to a further complication. In the Hydrocephalus Industry, too, the shunts used to relieve pressure from the brain may lead to infections and malfunctions. This causes a decline in the Hydrocephalus Industry share worldwide. Another restraint is the presence of irreversible brain damage due to accidents.

    Market Challenges

    The market challenges are the ones that can be solved and lead to more growth than limitation. The major challenge, according to market analysis of Hydrocephalus, is the need for research and development of advanced equipment and treatment in the Hydrocephalus Industry. There is a great scope to create an advanced approach to treating Hydrocephalus. However, this needs joint effort from the key players of the Hydrocephalus Industry. When the key players of the Market invest in the advancement of Hydrocephalic treatments, the Market will also progress.

    Hydrocephalus Market Segment Overview

    The Hydrocephalus Market Analysis points at the different segments of the Market. The Hydrocephalus Industry divides into categories based on type, diagnosis, treatment, and end-user.

    By Type- By type, the primary segments of the market are congenital Hydrocephalus and acquired Hydrocephalus.

    By diagnostic- By the way, Hydrocephalus is diagnosed, the Market divides into MRI, CT Scan, and head ultrasound.

    By surgery- By the surgery that is used to cure the condition, the market disperses into shunt insertion procedure, ventriculostomy, and medication to balance CSF.

    By end-user- The major end-user for the Market are hospitals, clinics, and diagnostics centers.

    Hydrocephalus Market Regional Analysis

    On the basis of the regional analysis for the market of Hydrocephalus, the American region, including North America and South America, will be the major regional markets for Hydrocephalus treatments. The companies that create Hydrocephalus treatment devices dominate the North American region. This then translates into regional dominance for the North American region. 

    There is much interest in the research and development of Hydrocephalus treatment in the region. This is especially true for the USA. However, the European regional market will be the second-largest market for Hydrocephalus treatments. Hydrocephalus in infancy will drive growth in the region.

    Competitive landscape 

    There are many key players in the Market that dominate the competitive landscape for the market. 

    The key players of the Hydrocephalus Market segment are as follows. 

    DePuy Synthes Boston Neurosciences Medtronic Integra Life Sciences Corporation Spiegelberg GmbH & Co. KG RAUMEDIC Inc Sophysa SA Terumo Corporation Natus Medical Incorporated Johnson & Johnson Services Inc

    Recent Developments

    The key competitors of the Market are investing in research and development of new, advanced Hydrocephalus treatment approaches. The Hydrocephalus Market forecast also predicts that the key players also take up a lot of mergers, collaborations, and acquisitions to achieve a common goal of supporting the Market of Hydrocephalus collectively. The research and development in the area of Hydrocephalus treatments will benefit all the major players of the Market.

    Report Overview 

    The Hydrocephalus Market Outlook or overview is as follows:

    Market Overview COVID 19 Analysis Market Dynamics Segment Overview Regional Analysis Competitive Landscape Recent Developments

    This report focuses on the market of Hydrocephalus and its trends. It highlights the key drivers, significant opportunities for growth and presents market challenges of the Hydrocephalus Industry. Thirdly, it discusses the segmentation of the Hydrocephalus Industry over various benchmarks and segments. Additionally, the Hydrocephalus Industry Outlook sheds more light on the competitive landscape and recent developments of the market. It creates an overall reading of the Hydrocephalus Industry Forecast for the readers. 

    The increasing prevalence of hydrocephalus, coupled with advancements in treatment options, suggests a growing demand for innovative healthcare solutions in the management of this condition.

    Centers for Disease Control and Prevention (CDC)

    Hydrocephalus Market Market Drivers

    Market Growth Projections

    The Global Hydrocephalus Market Industry is projected to experience substantial growth in the coming years. With an expected market value of 0.58 USD Billion in 2024, the industry is anticipated to reach 1.07 USD Billion by 2035. This growth reflects a compound annual growth rate (CAGR) of 5.77% from 2025 to 2035. Such projections indicate a robust demand for hydrocephalus treatments and technologies, driven by factors such as increasing prevalence, advancements in treatment, and heightened awareness.

    Rising Geriatric Population

    The increasing geriatric population globally is another significant driver for the Global Hydrocephalus Market Industry. Older adults are more susceptible to conditions that can lead to hydrocephalus, such as normal pressure hydrocephalus. As the global population ages, the demand for effective treatment options is likely to rise. This demographic shift necessitates enhanced healthcare services tailored to the elderly, thereby expanding the market. The Global Hydrocephalus Market Industry is poised for growth as healthcare systems adapt to meet the needs of this aging population.

    Growing Awareness and Education

    The growing awareness and education surrounding hydrocephalus are pivotal for the Global Hydrocephalus Market Industry. Increased efforts by healthcare organizations and advocacy groups to educate the public and healthcare professionals about hydrocephalus are leading to earlier diagnoses and better treatment options. Campaigns aimed at raising awareness have resulted in more individuals seeking medical advice, which in turn drives demand for treatments. This heightened awareness is expected to contribute to the market's growth trajectory, as more patients are identified and treated effectively.

    Government Initiatives and Funding

    Government initiatives aimed at improving healthcare infrastructure and funding for neurological disorders are vital for the Global Hydrocephalus Market Industry. Various countries are increasing their budgets for healthcare, focusing on conditions like hydrocephalus. For example, initiatives to enhance access to diagnostic tools and treatment options are being implemented in several nations. These efforts not only raise awareness but also facilitate early diagnosis and intervention, which are essential for effective treatment. As a result, the market is likely to expand, with projections indicating a rise to 1.07 USD Billion by 2035.

    Advancements in Treatment Technologies

    Innovations in treatment technologies are significantly influencing the Global Hydrocephalus Market Industry. Recent developments in shunt systems and endoscopic techniques have improved patient outcomes and reduced complications. For instance, programmable shunts allow for adjustable pressure settings, enhancing treatment efficacy. These advancements not only improve the quality of life for patients but also drive market growth as healthcare providers adopt these new technologies. The Global Hydrocephalus Market Industry is expected to benefit from these innovations, with a projected growth rate of 5.77% CAGR from 2025 to 2035.

    Increasing Prevalence of Hydrocephalus

    The rising incidence of hydrocephalus globally is a crucial driver for the Global Hydrocephalus Market Industry. Current estimates suggest that hydrocephalus affects approximately 1 in every 1,000 births, with a notable prevalence in developing regions. This increasing prevalence necessitates enhanced healthcare services and interventions, thereby expanding the market. As awareness grows, more patients seek treatment, contributing to market growth. The Global Hydrocephalus Market Industry is projected to reach 0.58 USD Billion in 2024, reflecting the urgent need for effective management solutions.

    Market Segment Insights

    Regional Insights

    Key Companies in the Hydrocephalus Market market include

    Industry Developments

    The key competitors of the Market are investing in research and development of new, advanced Hydrocephalus treatment approaches. The Hydrocephalus Market forecast also predicts that the key players also take up a lot of mergers, collaborations, and acquisitions to achieve a common goal of supporting the Market of Hydrocephalus collectively. The research and development in the area of Hydrocephalus treatments will benefit all the major players of the Market.

    Future Outlook

    Hydrocephalus Market Future Outlook

    The Hydrocephalus Market is poised for growth at 5.77% CAGR from 2024 to 2035, driven by advancements in treatment technologies, increasing awareness, and rising healthcare expenditure.

    New opportunities lie in:

    • Develop innovative shunt systems to enhance patient outcomes and reduce complications.
    • Invest in telemedicine solutions for remote monitoring of hydrocephalus patients.
    • Expand educational programs targeting healthcare professionals to improve diagnosis and treatment protocols.

    By 2035, the Hydrocephalus Market is expected to exhibit robust growth, reflecting advancements and increased demand.

    Market Segmentation

    Report Scope

    Attribute/Metric Details
    Market Size 2023 0.54 (USD Billion)
    Market Size 2024 0.58 (USD Billion)
    Market Size 2032 0.92 (USD Billion)
    Compound Annual Growth Rate (CAGR) 5.32 % (2024 - 2032)
    Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    Base Year 2023
    Market Forecast Period 2024 - 2032
    Historical Data 2019 - 2023
      Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
      Key Vendors   DePuy Synthes, Boston Neurosciences, Medtronic Plc, Integra LifeSciences Corporation, Spiegelberg GmbH & Co. KG, RAUMEDIC Inc, Sophysa SA, Terumo Corporation, Natus Medical Incorporated, Johnson & Johnson Services Inc, B. Braun Melsungen AG, Christoph Miethke GmbH & Co. KG, Tokibo Co., Ltd, HLL Lifecare Limited and others
      Key Market Opportunities   Investments in development of new shunts
      Key Market Drivers ·  Increasing prevalence of hydrocephalus ·  High incidence of traumatic brain injuries ·  Constant evaluation of various techniques

    Market Highlights

    Author

    Rahul Gotadki
    Assistant Manager

    She holds an experience of about 6+ years in market research and business consulting, working under the spectrum of information communication technology, telecommunications and semiconductor domains. aarti conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. her expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.

    Leave a Comment

    Latest Comments

    John Doe
    john@example.com

    This is a great article! Really helped me understand the topic better.

    Posted on July 23, 2025, 10:15 AM
    Jane Smith
    jane@domain.com

    Thanks for sharing this. I’ve bookmarked it for later reference.

    Posted on July 22, 2025, 7:45 PM

    FAQs

    What was the projected hydrocephalus market valuation in 2023?

    The hydrocephalus market valuation was USD 0.54 Billion in 2023.

    What is the projected CAGR of the hydrocephalus market during the forecast period of 2024-2032?

    The hydrocephalus market projected CAGR would be 5.32% for the forecast period.

    What are the end users discussed in the hydrocephalus market report?

    The end users are diagnostic centers, hospitals & clinics, academic institutions & research organizations.

    What are the segments based on diagnosis in the hydrocephalus market report?

    The segments are MRI, CT scan – head, and head ultrasound.

    Which region has the largest market share?

    America is leading the hydrocephalus market.

    1. Report Prologue
    2. Executive Summary
    3. Market Introduction
      1. Scope of Study 20
      2. Research Objective
      3. 20
      4. List
      5. of Assumptions 21
      6. 3.4
      7. Market Structure 21
      8. 4
      9. Research Methodology
      10. 4.1
      11. Research Process 23
      12. 4.2
      13. Primary Research 24
      14. 4.3
      15. Secondary Research 25
      16. 4.4
      17. Market Size Estimation 26
      18. Forecast Model 26
    4. Market Dynamics
      1. Introduction 28
      2. Drivers 29
        1. Growing Prevalence of Traumatic Brain Injuries
        2. Ongoing
        3. Favorable Reimbursement Policies Provide Favorable Background
        4. Increasing Prevalence of Neurovascular Diseases such as Brain
        5. Shortage of Trained Professionals 31
      3. 29
      4. Product Development & Commercialization Will Boost the Adoption of Hydrocephalus
      5. Shunts in the Market 29
      6. for the Market Growth 29
      7. Aneurysm, Arteriovenous Malformations (AVMs),
      8. and Others, are Likely to Propel the Hydrocephalus
      9. Market 30
      10. 5.3
      11. Restraints 31
      12. 5.3.1
      13. High Procedural Cost of ICP Monitoring Devices 31
      14. Opportunities 32
        1. Increase in Awareness
        2. Increasing Use of Endovascular Embolization
        3. Technological Advancements in Over the Wire Micro
      15. of Intraoperative Neurophysiological Monitoring (IONM) 32
      16. for the Treatment of Brain Aneurysm 32
      17. Guide Catheters 32
      18. 5.5
      19. Challenges 33
      20. 5.5.1
      21. Rising Partnership Among Competitors Leading to Rivalry 33
      22. Changing Economic Conditions Globally 33
    5. Market Factor Analysis
      1. Porter’s Five
        1. Bargaining Power of Buyers 36
        2. Threat of New Entrants 36
        3. Threat of Substitutes 36
        4. Intense Rivalry
      2. Forces Model 35
      3. 6.1.1
      4. Bargaining Power of Suppliers 35
      5. 36
      6. Value
        1. Post-Sales Monitoring 37
      7. chain analysis 37
      8. 6.2.1
      9. R&D 37
      10. 6.2.2
      11. Manufacturing 37
      12. 6.2.3
      13. Distribution & Sales 37
      14. Investment Opportunities 38
    6. Hydrocephalus Market, by Type
      1. Introduction 40
        1. Congenital Hydrocephalus
        2. Acquired
        3. Ex-Vacuo Hydrocephalus 42
      2. 41
      3. Hydrocephalus 41
      4. 7.1.3
      5. Normal-Pressure Hydrocephalus 42
    7. Hydrocephalus Market, by Diagnosis
      1. Introduction 44
        1. CT Scan–Head
        2. MRI
        3. Head
      2. 45
      3. 45
      4. Ultrasound 45
      5. 9
    8. Hydrocephalus Market, by Treatment
      1. Introduction 47
        1. Surgery–Shunt Insertion 48
        2. Ventriculostomy
        3. Medication
      2. 48
      3. 48
    9. Hydrocephalus
    10. Market, by End User
      1. 10.1
      2. Introduction 51
      3. 10.1.1
      4. Hospitals & Clinics 52
      5. 52
    11. Diagnostic Centres 52
    12. Academic Institutions and Research Organizations
    13. Global
    14. Hydrocephalus Market, by Region
      1. Introduction 54
      2. Americas 55
    15. Hydrocephalus Market, by Type
    16. Hydrocephalus Market, by Diagnosis
    17. Hydrocephalus Market, by Treatment
      1. Hydrocephalus Market,
      2. by End User
      3. 11.2.1
      4. North America 58
      5. Hydrocephalus
    18. Market, by Type
      1. Hydrocephalus
    19. Market, by Diagnosis
      1. Hydrocephalus
    20. Market, by Treatment
      1. Hydrocephalus
    21. Market, by End User
      1. 11.2.1.1
      2. US 60
      3. Hydrocephalus
    22. Market, by Type
      1. Hydrocephalus
    23. Market, by Diagnosis
      1. Hydrocephalus
    24. Market, by Treatment
      1. Hydrocephalus
    25. Market, by End User
      1. 11.2.1.2
      2. Canada 62
      3. Hydrocephalus
    26. Market, by Type
      1. Hydrocephalus
    27. Market, by Diagnosis
      1. Hydrocephalus
    28. Market, by Treatment
      1. Hydrocephalus
    29. Market, by End User
      1. 11.2.2
      2. South America 63
      3. Hydrocephalus
    30. Market, by Type
      1. Hydrocephalus
    31. Market, by Diagnosis
      1. Hydrocephalus
    32. Market, by Treatment
      1. Hydrocephalus
    33. Market, by End User
      1. 11.3
      2. Europe 66
      3. Hydrocephalus
    34. Market, by Type
      1. Hydrocephalus
    35. Market, by Diagnosis
      1. Hydrocephalus
    36. Market, by Treatment
      1. Hydrocephalus
    37. Market, by End User
      1. 11.4
      2. Western Europe 69
      3. Hydrocephalus
    38. Market, by Type
      1. Hydrocephalus
    39. Market, by Diagnosis
      1. Hydrocephalus
    40. Market, by Treatment
      1. Hydrocephalus
    41. Market, by End User
      1. 11.4.1
      2. Germany 71
      3. Hydrocephalus
    42. Market, by Type
      1. Hydrocephalus
    43. Market, by Diagnosis
      1. Hydrocephalus
    44. Market, by Treatment
      1. Hydrocephalus
    45. Market, by End User
      1. 11.4.2
      2. UK 73
      3. Hydrocephalus
    46. Market, by Type
      1. Hydrocephalus
    47. Market, by Diagnosis
      1. Hydrocephalus
    48. Market, by Treatment
      1. Hydrocephalus
    49. Market, by End User
      1. 11.4.3
      2. France 75
      3. Hydrocephalus
    50. Market, by Type
      1. Hydrocephalus
    51. Market, by Diagnosis
      1. Hydrocephalus
    52. Market, by Treatment
      1. Hydrocephalus
    53. Market, by End User
      1. 11.4.4
      2. Spain 76
      3. Hydrocephalus
    54. Market, by Type
      1. Hydrocephalus
    55. Market, by Diagnosis
      1. Hydrocephalus
    56. Market, by Treatment
      1. Hydrocephalus
    57. Market, by End User
      1. 11.4.5
      2. Italy 78
      3. Hydrocephalus
    58. Market, by Type
      1. Hydrocephalus
    59. Market, by Diagnosis
      1. Hydrocephalus
    60. Market, by Treatment
      1. Hydrocephalus
    61. Market, by End User
      1. 11.4.6
      2. Rest of Western Europe 80
    62. Hydrocephalus Market, by Type
    63. Hydrocephalus Market, by Diagnosis
    64. Hydrocephalus Market, by Treatment
      1. Hydrocephalus Market,
      2. by End User
      3. 11.4.7
      4. Eastern Europe 81
      5. Hydrocephalus
    65. Market, by Type
      1. Hydrocephalus
    66. Market, by Diagnosis
      1. Hydrocephalus
    67. Market, by Treatment
      1. Hydrocephalus
    68. Market, by End User
      1. 11.5
      2. Asia-Pacific 84
      3. Hydrocephalus
    69. Market, by Type
      1. Hydrocephalus
    70. Market, by Diagnosis
      1. Hydrocephalus
    71. Market, by Treatment
      1. Hydrocephalus
    72. Market, by End User
      1. 11.5.1
      2. China 86
      3. Hydrocephalus
    73. Market, by Type
      1. Hydrocephalus
    74. Market, by Diagnosis
      1. Hydrocephalus
    75. Market, by Treatment
      1. Hydrocephalus
    76. Market, by End User
      1. 11.5.2
      2. Japan 88
      3. Hydrocephalus
    77. Market, by Type
      1. Hydrocephalus
    78. Market, by Diagnosis
      1. Hydrocephalus
    79. Market, by Treatment
      1. Hydrocephalus
    80. Market, by End User
      1. 11.5.3
      2. India 90
      3. Hydrocephalus
    81. Market, by Type
      1. Hydrocephalus
    82. Market, by Diagnosis
      1. Hydrocephalus
    83. Market, by Treatment
      1. Hydrocephalus
    84. Market, by End User
      1. 11.5.4
      2. Australia 91
      3. Hydrocephalus
    85. Market, by Type
      1. Hydrocephalus
    86. Market, by Diagnosis
      1. Hydrocephalus
    87. Market, by Treatment
      1. Hydrocephalus
    88. Market, by End User
      1. 11.5.5
      2. South Korea 93
      3. Hydrocephalus
    89. Market, by Type
      1. Hydrocephalus
    90. Market, by Diagnosis
      1. Hydrocephalus
    91. Market, by Treatment
      1. Hydrocephalus
    92. Market, by End User
      1. 11.5.6
      2. Rest of Asia-Pacific 95
    93. Hydrocephalus Market, by Type
    94. Hydrocephalus Market, by Diagnosis
    95. Hydrocephalus Market, by Treatment
      1. Hydrocephalus Market,
      2. by End User
      3. 11.6
      4. Middle East & Africa 97
    96. Hydrocephalus Market, by Type
    97. Hydrocephalus Market, by Diagnosis
    98. Hydrocephalus Market, by Treatment
      1. Hydrocephalus Market,
      2. by End User
      3. 11.6.1
      4. Middle East 99
      5. Hydrocephalus
    99. Market, by Type
      1. Hydrocephalus
    100. Market, by Diagnosis
      1. Hydrocephalus
    101. Market, by Treatment
      1. Hydrocephalus
    102. Market, by End User
      1. 11.6.2
      2. Africa 101
      3. Hydrocephalus
    103. Market, by Type
      1. Hydrocephalus
    104. Market, by Diagnosis
      1. Hydrocephalus
    105. Market, by Treatment
      1. Hydrocephalus
    106. Market, by End User
      1. 12
      2. Competitive Landscape
      3. 12.1
      4. Competitive Scenario 104
      5. 106
    107. Introduction 104
      1. Company Market Share Analysis 105
        1. Introduction 105
      2. Key Developments
    108. Company
      1. Profiles
      2. 13.1
      3. DePuy Synthes 109
      4. 13.1.1
      5. Company Overview 109
      6. 13.1.2
      7. Financial Overview 109
      8. 13.1.3
      9. Products Offered 110
      10. 13.1.4
      11. Key Developments 110
      12. 13.1.5
      13. SWOT Analysis 110
      14. 13.1.6
      15. Key Strategies 110
      16. 13.2
      17. Boston Neurosciences 111
      18. 115
      19. 13.4.2
      20. Financial Overview 115
      21. 13.4.3
      22. Products Offered 116
      23. 13.4.4
      24. Key Developments 117
      25. 13.4.5
      26. SWOT Analysis 118
      27. 13.4.6
      28. Key Strategies 118
      29. 13.5
      30. Spiegelberg GmbH & Co. KG 119
      31. 126
      32. 13.9.3
      33. Products Offered 127
      34. 13.9.4
      35. Key Developments 127
      36. 13.9.5
      37. SWOT Analysis 127
      38. 13.9.6
      39. Key Strategies 127
      40. 13.10
      41. Johnson & Johnson Services Inc. 128
      42. 129
      43. 13.10.5
      44. SWOT Analysis 129
      45. 13.10.6
      46. Key Strategies 130
      47. 13.11
      48. B. Braun Melsungen AG 131
      49. 132
      50. 13.11.4
      51. Key Developments 132
      52. 13.11.5
      53. SWOT Analysis 132
      54. 13.11.6
      55. 133
      56. 13.12.5
      57. SWOT Analysis 133
      58. 13.12.6
      59. Key Strategies 133
      60. 13.13
      61. Tokibo Co., Ltd. 134
      62. 13.13.1
      63. Company Overview 134
      64. 13.13.2
      65. Financial Overview 134
      66. 13.13.3
      67. Products Offered 134
      68. 13.13.4
      69. Key Developments 134
      70. 13.13.5
      71. SWOT Analysis 134
      72. 13.13.6
      73. Key Strategies 134
      74. 13.14
      75. HLL Lifecare Limited 135
      76. 135
      77. 13.14.5
      78. SWOT Analysis 135
      79. 13.14.6
      80. Key Strategies 135
      81. 14
      82. Appendix
      83. 14.1
      84. Discussion Blue Print 137
    109. Company Overview 111
    110. Financial Overview 111
    111. Products Offered 111
    112. Key Developments 111
    113. SWOT Analysis 111
    114. Key Strategies 111
      1. Medtronic Plc 112
        1. Company Overview 112
        2. Financial Overview 112
        3. Products Offered 113
        4. Key Developments 113
        5. SWOT Analysis 113
        6. Key Strategies 114
      2. Integra LifeSciences Corporation 115
        1. Company Overview
        2. Company Overview 119
        3. Financial Overview 119
        4. Products Offered 119
        5. Key Developments 119
        6. SWOT Analysis 119
        7. Key Strategies 120
      3. RAUMEDIC Inc. 121
        1. Company Overview 121
        2. Financial Overview 121
        3. Products Offered 121
        4. Key Developments 121
        5. SWOT Analysis 121
        6. Key Strategies 121
      4. Sophysa SA 122
        1. Company Overview 122
        2. Financial Overview 122
        3. Products Offered 122
        4. Key Developments 122
        5. SWOT Analysis 123
        6. Key Strategies 123
      5. Terumo Corporation 124
        1. Company Overview 124
        2. Financial Overview 124
        3. Products Offered 125
        4. Key Developments 125
        5. SWOT Analysis 125
        6. Key Strategies 125
      6. Natus Medical Incorporated 126
        1. Company Overview 126
        2. Financial Overview
        3. Company Overview 128
        4. Financial Overview 128
        5. Products Offered 129
        6. Key Developments
        7. Company Overview 131
        8. Financial Overview 131
        9. 1.10.3 Products Offered
        10. Key Strategies 132
      7. Christoph Miethke GmbH & Co. KG 133
        1. Company Overview 133
        2. Financial Overview 133
        3. Products Offered 133
        4. Key Developments
        5. Company Overview 135
        6. Financial Overview 135
        7. Products Offered 135
        8. Key Developments
    115. List of Tables
    116. MARKET SYNOPSIS 18
    117. LIST OF ASSUMPTIONS 21
    118. GLOBAL HYDROCEPHALUS MARKET, BY TYPE 2020–2027
      1. (USD MILLION) 40
      2. TABLE
    119. GLOBAL HYDROCEPHALUS MARKET FOR CONGENITAL HYDROCEPHALUS, BY REGION 2020–2027
      1. (USD MILLION) 41
      2. TABLE
    120. GLOBAL HYDROCEPHALUS MARKET FOR ACQUIRED HYDROCEPHALUS, BY REGION 2020–2027
      1. (USD MILLION) 41
      2. TABLE
    121. GLOBAL HYDROCEPHALUS MARKET FOR NORMAL-PRESSURE HYDROCEPHALUS, BY REGION 2020–2027
      1. (USD MILLION) 42
      2. TABLE
    122. GLOBAL HYDROCEPHALUS MARKET FOR EX-VACUO HYDROCEPHALUS, BY REGION 2020–2027
      1. (USD MILLION) 42
      2. TABLE
    123. GLOBAL HYDROCEPHALUS MARKET, BY DIAGNOSIS 2020–2027 (USD MILLION) 44
    124. GLOBAL HYDROCEPHALUS
      1. MARKET, FOR CT SCAN–HEAD BY REGION 2020–2027 (USD MILLION) 45
    125. GLOBAL HYDROCEPHALUS
      1. MARKET, FOR MRI BY REGION 2020–2027 (USD MILLION) 45
    126. GLOBAL HYDROCEPHALUS MARKET FOR HEAD ULTRASOUND,
      1. BY REGION 2020–2027 (USD MILLION) 45
    127. GLOBAL HYDROCEPHALUS MARKET, BY TREATMENT2020–2027
      1. (USD MILLION) 47
      2. TABLE
    128. GLOBAL HYDROCEPHALUS MARKET, FOR SURGERY–SHUNT INSERTION BY REGION, 2020–2027
      1. (USD MILLION) 48
      2. TABLE
    129. GLOBAL HYDROCEPHALUS MARKET, FOR VENTRICULOSTOMY BY REGION, 2020–2027 (USD
      1. MILLION) 48
      2. TABLE
    130. GLOBAL HYDROCEPHALUS MARKET, FOR MEDICATION BY TYPE, 2020–2027 (USD MILLION)
      1. 48
      2. TABLE 16
      3. GLOBAL HYDROCEPHALUS MARKET, FOR MEDICATION BY REGION, 2020–2027 (USD MILLION)
      4. 49
      5. TABLE 17
    131. GLOBAL HYDROCEPHALUS MARKET, BY END USER 2020–2027 (USD MILLION) 51
    132. GLOBAL HYDROCEPHALUS
    133. MARKET FOR HOSPITALS & CLINICS, BY REGION 2020–2027 (USD MILLION) 52
    134. GLOBAL HYDROCEPHALUS
    135. MARKET FOR DIAGNOSTIC CENTERS, BY REGION 2020–2027 (USD MILLION) 52
    136. GLOBAL HYDROCEPHALUS
    137. MARKET FOR ACADEMIC INSTITUTIONS AND RESEARCH ORGANIZATIONS, BY REGION 2020–2027
      1. (USD MIL

    Hydrocephalus Market Segmentation

    Market Segmentation Overview

    • Detailed segmentation data will be available in the full report
    • Comprehensive analysis by multiple parameters
    • Regional and country-level breakdowns
    • Market size forecasts by segment
    Infographic

    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Get Free Sample

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne

    Founder
    Case Study
    Chemicals and Materials